Pacer Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-552
Closed -$11.4K 2661
2024
Q2
$11.4K Sell
552
-858
-61% -$18.6K ﹤0.01% 3526
2024
Q1
$34.9K Buy
+1,410
New +$41.9K ﹤0.01% 3311
2021
Q2
Sell
-952
Closed -$24K 1516
2021
Q1
$24K Buy
+952
New +$17.9K ﹤0.01% 1497

Other funds holding PRTA

Pacer Advisors's PRTA Position: Q3 2024 in Review

Pacer Advisors sold out of Prothena Corp (PRTA) in Q3 2024, closing a stake of 552 shares — an estimated $11.4K sold.

Pacer Advisors first reported a position in PRTA in Q1 2021 and held it in 3 quarters. The position peaked at $34.9K in Q1 2024. 164 funds tracked by Wall St. Rank hold PRTA as of Q3 2024.

  • Pacer Advisors reported no remaining Prothena Corp position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 552 Prothena Corp shares in Q3 2024, an estimated $11.4K.
  • Pacer Advisors first reported a position in Prothena Corp in Q1 2021 and held it in 3 quarters.
  • Pacer Advisors's Prothena Corp position peaked at $34.9K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.